tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
RegenXBio (RGNX)
NASDAQ:RGNX
US Market
RGNX
RegenXBio
RESEARCH TOOLSreports

RegenXBio (RGNX) Stock News & Sentiment

Compare
1,041 Followers
RegenXBio: Clinical Hold on RGX-111/121 Seen as Manageable Timing Issue, Core Gene Therapy Platform and Key Value Drivers Remain Intact Supporting Buy Rating
Premium
Ratings
RegenXBio: Clinical Hold on RGX-111/121 Seen as Manageable Timing Issue, Core Gene Therapy Platform and Key Value Drivers Remain Intact Supporting Buy Rating
2d ago
RGNX
FDA Halts RegenXBio MPS Gene Therapy Trials
Premium
Company Announcements
FDA Halts RegenXBio MPS Gene Therapy Trials
2d ago
8K
RGNX
RegenXBio: Advancing Gene Therapy Pipeline and Near‑Term Regulatory Catalysts Underpin Buy Rating
Premium
Ratings
RegenXBio: Advancing Gene Therapy Pipeline and Near‑Term Regulatory Catalysts Underpin Buy Rating
18d ago
RGNX
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
1M ago
PYXS
RGNX
RegenXBio’s Strategic Positioning and Advancements Drive Buy Rating Amid Market Opportunities
Premium
Ratings
RegenXBio’s Strategic Positioning and Advancements Drive Buy Rating Amid Market Opportunities
2M ago
RGNX
RegenXBio’s Gene Therapy Study for Hunter Syndrome: A Potential Game-Changer
Premium
Company Announcements
RegenXBio’s Gene Therapy Study for Hunter Syndrome: A Potential Game-Changer
2M ago
RGNX
RegenXBio’s Strategic Manufacturing and Commercial Readiness Justifies Buy Rating and $34 Price Target
Premium
Ratings
RegenXBio’s Strategic Manufacturing and Commercial Readiness Justifies Buy Rating and $34 Price Target
2M ago
RGNX
More RGNX News >

RGNX News on the Web

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Armata Pharmaceuticals (ARMP) and Halozyme (HALO)
TipRanks News
Bullish
Chardan Capital Remains a Buy on RegenXBio (RGNX)
TipRanks News
Bullish
RegenXBio: Clinical Hold on RGX-111/121 Seen as Manageable Timing Issue, Core Gene Therapy Platform and Key Value Drivers Remain Intact Supporting Buy Rating
TipRanks News
Bullish
Stifel says Regenxbio’s RGX-121 delay not unexpected, not difficult to resolve
TipRanks News
Bullish
Midday Fly By: AT&T reports Q4 beat, Amazon cuts 16,000 jobs
TipRanks News
Bearish
Regenxbio selloff ‘an overreaction’ to clinical hold, says Leerink
TipRanks News
Bullish
Regenxbio clinical hold does not change thesis, says Clear Street
TipRanks News
Neutral
FDA Halts RegenXBio MPS Gene Therapy Trials
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
RGNX
Sector Average
Media Buzz
This Week13 articles
Weekly Average5.75 articles
News Sentiment
This Week55%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RGNX’s Media Buzz Sentiment?
13 articles about RGNX were published this week. In an average week, 5.75 articles are published.
    What is RGNX’s weekly average amount of articles?
    In an average week, 5.75 articles about RGNX are published.
      What is RGNX’s News Sentiment?
      55% of articles about RGNX were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        KRROKorro Bio
        IMAImageneBio
        Showing the stocks with the most bullish news sentiment over the past week